Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
73.45
-0.43 (-0.59%)
Oct 29, 2025, 2:22 PM EDT - Market open
PBE Holdings Information
PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Incyte stock at 5.11%, Biogen at 5.07%, Vertex Pharmaceuticals at 5.01%, Gilead Sciences at 4.84%, and Royalty Pharma at 4.78%.
Total Holdings
25
Top 10 Percentage
46.55%
Asset Class
Equity
ETF Category
n/a
Assets
229.72M
PE Ratio
17.77
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | INCY | Incyte Corporation | 5.11% |
| 2 | BIIB | Biogen Inc. | 5.07% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 5.01% |
| 4 | GILD | Gilead Sciences, Inc. | 4.84% |
| 5 | RPRX | Royalty Pharma plc | 4.78% |
| 6 | ILMN | Illumina, Inc. | 4.69% |
| 7 | AMGN | Amgen Inc. | 4.64% |
| 8 | REGN | Regeneron Pharmaceuticals, Inc. | 4.59% |
| 9 | IONS | Ionis Pharmaceuticals, Inc. | 4.35% |
| 10 | EXAS | Exact Sciences Corporation | 3.46% |
| 11 | UTHR | United Therapeutics Corporation | 3.43% |
| 12 | PTCT | PTC Therapeutics, Inc. | 3.41% |
| 13 | MNKD | MannKind Corporation | 3.35% |
| 14 | SRPT | Sarepta Therapeutics, Inc. | 3.24% |
| 15 | VCYT | Veracyte, Inc. | 3.11% |
| 16 | TECH | Bio-Techne Corporation | 2.85% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 2.74% |
| 18 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.70% |
| 19 | EXEL | Exelixis, Inc. | 2.62% |
| 20 | AKBA | Akebia Therapeutics, Inc. | 2.58% |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.58% |
| 22 | DVAX | Dynavax Technologies Corporation | 2.53% |
| 23 | VCEL | Vericel Corporation | 2.52% |
| 24 | QGEN | Qiagen N.V. | 2.49% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 2.31% |
As of Oct 27, 2025